High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B
- PMID: 1829615
High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B
Abstract
A eukaryotic vector-host cell system is described where the additive transactivating effects of HIV-1 tat and adenovirus E1A on HIV-1 long terminal repeat (LTR) are exploited to increase expression of exogenous cDNAs. Human 143B and 293 cells, the latter constitutively producing E1A, were used as host cell lines. The bacterial gene chloramphenicol acetyltransferase (CAT) and the hepatitis B surface antigen (HBs-Ag) gene were employed as reporter genes inserted in pRPneoU3R, an episomal vector containing BK virus replication origin and early region, where cDNAs are expressed under control of HIV-1 LTR. The 293 cells were transformed by tat expression vectors to constitutively express tat. Stable cell clones of 293tat cells, constitutively expressing CAT after transformation with pRPneoU3R-CAT, show a CAT activity 600-fold higher than normal 293 transformed cells. CAT expression obtained in normal 293 cells can be transiently increased 10-fold by transfection by vectors expressing tat. The 293tat cells transformed by pRPneoU3R-HBs, an episomal vector expressing HBs-Ag from HIV LTR, yielded stable cell clones secreting HBs-Ag in the culture medium at a concentration up to 744 ng/ml or 44 ng/10(6) cells/24 h, 48-fold more than normal 293 cells. The use of this system for constitutive or inducible expression of sequences under control of HIV-1 LTR is discussed in view of possible applications for diagnostic, vaccinal and therapeutic purposes.
Similar articles
-
Retroviral vector with a CMV-IE/HIV-TAR hybrid LTR gives high basal expression levels and is up-regulated by HIV-1 Tat.Gene Ther. 1995 Jun;2(4):269-78. Gene Ther. 1995. PMID: 7552987
-
Evaluation of relative promoter strengths of the HIV-1-LTR and a chimeric RSV-LTR in T lymphocytic cells and peripheral blood mononuclear cells: promoters for anti-HIV-1 gene therapies.Gene Ther. 1996 Aug;3(8):725-30. Gene Ther. 1996. PMID: 8854098
-
Histone-mediated transfer and expression of the HIV-1 tat gene in Jurkat cells.J Hum Virol. 1998 Nov-Dec;1(7):430-40. J Hum Virol. 1998. PMID: 10195264
-
An autocrine loop of HIV type-1 Tat protein responsible for the improved survival/proliferation capacity of permanently Tat-transfected cells and required for optimal HIV-1 LTR transactivating activity.J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Nov 1;10(3):306-16. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 7552492
-
The human immunodeficiency virus type-1 (HIV-1) Tat protein and Bcl-2 gene expression.Leuk Lymphoma. 1996 Nov;23(5-6):551-60. doi: 10.3109/10428199609054864. Leuk Lymphoma. 1996. PMID: 9031086 Review.
Cited by
-
Duplication of the primary encapsidation and dimer linkage region of human immunodeficiency virus type 1 RNA results in the appearance of monomeric RNA in virions.J Virol. 2001 Mar;75(6):2557-65. doi: 10.1128/JVI.75.6.2557-2565.2001. J Virol. 2001. PMID: 11222678 Free PMC article.
-
Human immunodeficiency virus type 1 RNA outside the primary encapsidation and dimer linkage region affects RNA dimer stability in vivo.J Virol. 1997 Apr;71(4):3250-4. doi: 10.1128/JVI.71.4.3250-3254.1997. J Virol. 1997. PMID: 9060689 Free PMC article.
-
A BK virus episomal vector for constitutive high expression of exogenous cDNAs in human cells.Arch Virol. 1995;140(2):335-9. doi: 10.1007/BF01309866. Arch Virol. 1995. PMID: 7710358
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous